DIRUI shares the clinical evaluation report of FUS-3000Plus from Bangladesh
December 11, 2023
The clinical evaluation report of FUS-3000Plus in the international marketThe largest medical university hospital in Bangladesh has installed 3 sets of urinalysis systems from Dirui and also installed a set of European brand urine workstations and a set of Asian brand urine workstations. Every day, the hospital needs to test more than 1500 samples, and Dirui's urinalysis tests more than 50% of the samples. The evaluation was hosted by the director of the laboratory, who has a wealth of experience in clinical pathology, medical biochemistry, and clinical routine urinalysis fields and is good at clinical consulting, teaching, and academic research. The laboratory's director is highly recognition for the evaluation results. During the 15-day evaluation, to ensure the accuracy and reliability of the evaluation results, Urine Product Specialist Rebecca Zhou tested 500 unknown samples on the FUS-3000Plus and recorded tested data.
The results of the evaluation: The accuracy and repeatability of dry chemistry and formed elements results from FUS-3000Plus meet industrial standards. The FUS-3000Plus achieved a 96% compliance rate for RBC, a 94.2% compliance rate for WBC, and a 93.2% compliance rate for SQEP when compared to the gold standard. The FUS-3000Plus excels in automatic classification, image rechecks particle recognition, and convenient disease diagnosis for the software. Especially for high-concentration samples, it has a high detection rate and provides accurate classification results.
#FUS3000PLUS #Urinalysis #Sediment #GoldStandard
Contact sales@jingquanmedical.com for more introduction of analysis solutions.